SCHEMBL7716696

SCHEMBL7716696

CCc1cc2c(cc1Oc1ccc(C(=O)O)cc1C)C(C)(C)CCC2(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 20/20 0.62
HNF4A P41235 1/20 0.52
RXRG P48443 8/20 0.49
RXRB P28702 7/20 0.49
RARA P10276 3/20 0.49
RARB P10826 3/20 0.49
RARG P13631 3/20 0.49
MEN1 O00255 1/20 0.47
CYP26A1 O43174 1/20 0.47
ABCB11 O95342 1/20 0.47
ESR1 P03372 1/20 0.47
PGR P06401 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD1 P21728 1/20 0.47
TBXA2R P21731 1/20 0.47
SLC6A2 P23975 1/20 0.47
ADRA1A P35348 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8014342 0.88 RXRA (0.50) RXRAHNF4ARXRGRXRBRARA
SCHEMBL7721760 0.85 RXRA (0.71) RXRAHNF4ARXRGRXRBRARA
SCHEMBL6910205 0.77 RXRA (1.00) RXRARXRGRXRBRARARARB
SCHEMBL272042 0.77 CA12 (0.57) RXRAMEN1ESR1KMT2A
SCHEMBL8016720 0.75 CYP3A4 (0.56) RXRAHNF4ARXRGRXRBRARA
SCHEMBL8310066 0.75 RXRA (0.57) RXRARXRGRXRBRARARARB
SCHEMBL28032622 0.73 CA12 (0.53) MEN1KMT2A
SCHEMBL9868375 0.73 RXRA (0.73) RXRARXRGRXRBRARARARB
SCHEMBL1072441 0.71 RXRA (1.00) RXRAHNF4ARXRGRXRBRARA
SCHEMBL6240778 0.71 RXRA (0.72) RXRAHNF4ARXRGRXRBCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US claimed
EP-1019049-A1 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS Galderma Research & Development, S.N.C. (FR) 2000-07-19 EP claimed
WO-1998042340-A9 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS 1999-03-04 WO claimed
WO-1998042340-A1 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 1998-10-01 WO claimed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US claimed
EP-0679630-B1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses CIRD GALDERMA (FR) 1998-05-06 EP claimed
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US disclosed
US-6162815-A RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-19 US disclosed
US-6156788-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-05 US disclosed
EP-1019049-A1 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) USING SPECIFIC RETINOID COMPOUNDS Galderma Research & Development, S.N.C. (FR) 2000-07-19 EP disclosed
US-6015569-A PYRIDINE OR PYRROLE DERIVATIVES OF POLYCYCLIC AROMATICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-01-18 US disclosed
WO-1998042340-A9 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS 1999-03-04 WO disclosed
WO-1998042340-A1 RETINOID RELATED MOLECULES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 1998-10-01 WO disclosed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US disclosed
EP-0679630-B1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses CIRD GALDERMA (FR) 1998-05-06 EP disclosed
EP-0679630-A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1995-11-02 EP disclosed